Synthesis of New bis-furanyl-pyrrolo[3,4-b]pyridin-5-ones via the Ugi-Zhu Reaction and Docking Studies on the Main Protease (MPro) from SARS-CoV-2

ECSOC-25 Pub Date : 2021-11-14 DOI:10.3390/ecsoc-25-11771
Ivette Morales-Salazar, S. L. Castañón-Alonso, Daniel Canseco-González, E. Díaz-Cervantes, E. González-Zamora, A. Islas-Jácome
{"title":"Synthesis of New bis-furanyl-pyrrolo[3,4-b]pyridin-5-ones via the Ugi-Zhu Reaction and Docking Studies on the Main Protease (MPro) from SARS-CoV-2","authors":"Ivette Morales-Salazar, S. L. Castañón-Alonso, Daniel Canseco-González, E. Díaz-Cervantes, E. González-Zamora, A. Islas-Jácome","doi":"10.3390/ecsoc-25-11771","DOIUrl":null,"url":null,"abstract":": The synthesis of five new bis -furanyl-pyrrolo[3,4-b ]pyridin-5-ones in 30 to 40% yields through a domino sequence based on the Ugi-Zhu three-component reaction is described. Then, on the main protease M Pro (PDB: 6lu7) from the SARS-CoV-2, the synthesized products and co-crystallized ligands of M Pro were in silico evaluated using the docking technique, finding moderate to good binding energies and some interesting interactions, demonstrating that the ligand 8c can be considered as a drug candidate against the SARS-CoV-2-M Pro due to its LE value ( − 5.96 kcal/mol), which is better than other synthesized and reported molecules in the literature. At the same time, hydrophobic interactions play a crucial role in the ligand target molecular couplings, demonstrated through a hydrophobicity surfaces analysis. Finally, 8a and 8b can also be considered as drug candidates. Thus, some synthesized bis -furanyl-pyrrolo[3,4-b ]pyridin-5-ones may be used for further in vitro assays against the virus.","PeriodicalId":11441,"journal":{"name":"ECSOC-25","volume":"11 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ECSOC-25","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/ecsoc-25-11771","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: The synthesis of five new bis -furanyl-pyrrolo[3,4-b ]pyridin-5-ones in 30 to 40% yields through a domino sequence based on the Ugi-Zhu three-component reaction is described. Then, on the main protease M Pro (PDB: 6lu7) from the SARS-CoV-2, the synthesized products and co-crystallized ligands of M Pro were in silico evaluated using the docking technique, finding moderate to good binding energies and some interesting interactions, demonstrating that the ligand 8c can be considered as a drug candidate against the SARS-CoV-2-M Pro due to its LE value ( − 5.96 kcal/mol), which is better than other synthesized and reported molecules in the literature. At the same time, hydrophobic interactions play a crucial role in the ligand target molecular couplings, demonstrated through a hydrophobicity surfaces analysis. Finally, 8a and 8b can also be considered as drug candidates. Thus, some synthesized bis -furanyl-pyrrolo[3,4-b ]pyridin-5-ones may be used for further in vitro assays against the virus.
新型双呋喃基吡咯[3,4-b]吡啶-5- 1的Ugi-Zhu反应合成及SARS-CoV-2主蛋白酶(MPro)对接研究
以Ugi-Zhu三组分反应为基础,采用多米诺骨牌顺序合成了5个新的双呋喃基吡啶[3,4-b]吡啶-5- 1,产率为30 ~ 40%。然后,在SARS-CoV-2的主要蛋白酶M Pro (PDB: 6lu7)上,利用对接技术对M Pro的合成产物和共结晶配体进行了硅评价,发现了中至良好的结合能和一些有趣的相互作用,表明配体8c的LE值(- 5.96 kcal/mol)优于文献中其他合成和报道的分子,可以考虑作为抗SARS-CoV-2-M Pro的候选药物。同时,疏水相互作用在配体-靶分子偶联中起着至关重要的作用,这一点通过疏水表面分析得到了证明。最后,8a和8b也可以考虑作为候选药物。因此,一些合成的双-呋喃基吡咯[3,4-b]吡啶-5- 1可用于进一步的体外抗病毒试验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信